The Indian Journal of Pediatrics

, Volume 76, Issue 10, pp 1065–1066 | Cite as

Stimulating platelet production to raise platelet count in immune thrombocytopenic purpura: A novel approach

Annotation
  • 40 Downloads

References

  1. 1.
    Cines BD, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244–2251.CrossRefPubMedGoogle Scholar
  2. 2.
    McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Seminar Hematol 2000;239–248.Google Scholar
  3. 3.
    Bussel JB, Provan D, Shamsi T et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial. Lancet 2009;373:641–648.CrossRefPubMedGoogle Scholar
  4. 4.
    Chang M, Nakagawa PA, Williams SA et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inibit megakaryopoiesis in vitro. Blood 2003;102:887–895.CrossRefPubMedGoogle Scholar
  5. 5.
    Hoffman R, Mazur E, Bruno E, Floyd V. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies N Engl J Med 1981;305:533–538.PubMedCrossRefGoogle Scholar
  6. 6.
    Nomura S, Dan K, Hotta T, Fujimura K, Ikeda Y. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 2002;100:728–730.CrossRefPubMedGoogle Scholar
  7. 7.
    Li J, Yang C, Xia Y et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 2001;98:3241–48.CrossRefPubMedGoogle Scholar
  8. 8.
    Basser R, O’Flaherty E, Green M et al. Development of pancytopenia with neutralising antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 2002, 99:2599–2602.CrossRefPubMedGoogle Scholar
  9. 9.
    Broudy VC, Lin NL. AMG 531 stimulates megakarypoiesis invitro by binding to Mpl. Cytokine 2004;25:52–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Bussel JB, Kuter DJ, George JN et al. AMG-531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006;355:1672–1681.CrossRefPubMedGoogle Scholar
  11. 11.
    Newland A, Caulier MT, Kappers-Klune M et al. An openlabel, unit dose-finding study of AMG-531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura. Br J Haematol 2006;135:547–553.CrossRefPubMedGoogle Scholar
  12. 12.
    George JN, Mathias SD, Go RS et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol 2008;144:409–415.CrossRefPubMedGoogle Scholar
  13. 13.
    Bussel JB, Chang G, Saleh MN et al. Eltrombopag for treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007;357:2237–2247.CrossRefPubMedGoogle Scholar
  14. 14.
    Bussel JB, Provan D, Shamsi T et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial. Lancet 2009;373:641–648.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2009

Authors and Affiliations

  1. 1.Division of Pediatric Hematology, Department of PediatricsLady Hardinge Medical College, Kalawati Saran Children’s HospitalNew DelhiIndia
  2. 2.Sunflag Pahuja Centre for Blood Disorders Sunflag HospitalFaridabadIndia

Personalised recommendations